Structural Virology: The Key Determinants in Development of Antiviral Therapeutics
Open Access
Abstract
Structural virology has emerged as the foundation for the development of effective antiviral therapeutics. It is pivotal in providing crucial insights into the three-dimensional frame of viruses and viral proteins at atomic-level or near-atomic-level resolution. Structure-based assessment of viral components, including capsids, envelope proteins, replication machinery, and host interaction interfaces, is instrumental in unraveling the multiplex mechanisms of viral infection, replication, and pathogenesis. The structural elucidation of viral enzymes, including proteases, polymerases, and integrases, has been essential in combating viruses like HIV-1 and HIV-2, SARS-CoV-2, and influenza. Techniques including X-ray crystallography, Nuclear Magnetic Resonance spectroscopy, Cryo-electron Microscopy, and Cryo-electron Tomography have revolutionized the field of virology and significantly aided in the discovery of antiviral therapeutics. The ubiquity of chronic viral infections, along with the emergence and reemergence of new viral threats necessitate the development of novel antiviral strategies and agents, while the extensive structural diversity of viruses and their high mutation rates further underscore the critical need for structural analysis of viral proteins to aid antiviral development. This review highlights the significance of structure-based investigations for bridging the gap between structure and function, thus facilitating the development of effective antiviral therapeutics, vaccines, and antibodies for tackling emerging viral threats.Keywords
All Related Versions
Funding Information
- Scheme for Transformational and Advanced Research in Sciences (STARS), Ministry of Education (MoE) (STARS2/2023–0209)
This publication has 333 references indexed in Scilit:
- Rational Design of Antiviral Therapeutics2024
- Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV‐2 targeting main protease and papain‐like proteaseIUBMB Life, 2023
- Adaptation‐Proof SARS‐CoV‐2 Vaccine DesignAdvanced Functional Materials, 2022
- A brief review of influenza virus infectionJournal of Medical Virology, 2021
- Inhibition of Chikungunya virus by an adenosine analog targeting the SAM‐dependent nsP1 methyltransferaseFEBS Letters, 2019
- Searching for human oncoviruses: Histories, challenges, and opportunitiesJournal of Cellular Biochemistry, 2018
- Serendipitous Discovery of a Potent Influenza Virus A Neuraminidase InhibitorAngewandte Chemie International Edition, 2013
- Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesionsInternational Journal of Cancer, 2007
- Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase 1 1Edited by M. F. SummersJournal of Molecular Biology, 2001
- The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanismJournal of Molecular Biology, 1999